ADAR1 Capital Management »

Amplify Energy Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Amplify Energy Corp (AMPY) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Amplify Energy Corp

Tip: Access up to 7 years of quarterly data

All positions including Amplify Energy Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amplify Energy Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $47k 7.1k 6.61
2023-12-31 $42k 7.1k 5.93

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Amplify Energy Corp

BlackRock
BlackRock
Vanguard Group
Dimensional Fund Advisors
Bridgeway Capital Management
Geode Capital Management
American Century Companies
State Street Corporation
Foundry Partners
Susquehanna International
Acadian Asset Management
Morgan Stanley
Bank of New York Mellon
Citadel Advisors
AQR Capital Management

View all funds holding Amplify Energy Corp